首页> 外文期刊>Cell Communication and Signaling >Serotonin induced hepatic steatosis is associated with modulation of autophagy and notch signaling pathway
【24h】

Serotonin induced hepatic steatosis is associated with modulation of autophagy and notch signaling pathway

机译:血清素诱导的肝脂肪变性与自噬和刻槽信号通路的调节有关

获取原文
           

摘要

Besides its neurotransmitter and vasoconstriction functions, serotonin is an important mediator of numerous biological processes in peripheral tissues including cell proliferation, steatosis, and fibrogenesis. Recent reports indicate that serotonin may promote tumor growth in liver cancer, however, the molecular mechanisms remain elusive. n this study, we investigated the role and molecular signaling mechanisms mediated by serotonin in liver cancer cell survival, drug resistance, and steatosis. Effect of serotonin on modulation of cell survival/proliferation was determined by MTT/WST1 assay. Effect of serotonin on the regulation of autophagy biomarkers and lipid/fatty acid proteins expression, AKT/mTOR and Notch signaling was evaluated by immunoblotting. The role of serotonin in normal human hepatocytes and liver cancer cell steatosis was analyzed by Oil Red O staining. The mRNA expression levels of lipid/fatty acid proteins and serotonin receptors were validated by qRT-PCR. The important roles of autophagy, Notch signaling, serotonin receptors and serotonin re-uptake proteins on serotonin-mediated cell steatosis were investigated by using selective inhibitors or antagonists. The association of peripheral serotonin, autophagy, and hepatic steatosis was also investigated using chronic EtOH fed mouse model. Exposure of liver cancer cells to serotonin induced Notch signaling and autophagy, independent of AKT/mTOR pathway. Also, serotonin enhanced cancer cell proliferation/survival and drug resistance. Furthermore, serotonin treatment up-regulated the expression of lipogenic proteins and increased steatosis in liver cancer cells. Inhibition of autophagy or Notch signaling reduced serotonin-mediated cell steatosis. Treatment with serotonin receptor antagonists 5-HTr1B and 5-HTr2B reduced serotonin-mediated cell steatosis; in contrast, treatment with selective serotonin reuptake inhibitors (SSRIs) increased steatosis. In addition, mice fed with chronic EtOH resulted in increased serum serotonin levels which were associated with the induction of hepatic steatosis and autophagy. Serotonin regulates liver cancer cell steatosis, cells survival, and may promote liver carcinogenesis by activation of Notch signaling and autophagy.
机译:血清素除了具有神经递质和血管收缩功能外,还是外周组织众多生物过程的重要介质,包括细胞增殖,脂肪变性和纤维化。最近的报道表明,血清素可能促进肝癌中的肿瘤生长,但是其分子机制仍然难以捉摸。在这项研究中,我们研究了血清素介导的在肝癌细胞存活,耐药性和脂肪变性中的作用和分子信号传导机制。通过MTT / WST1测定确定5-羟色胺对细胞存活/增殖的调节作用。通过免疫印迹评估5-羟色胺对自噬生物标志物和脂质/脂肪酸蛋白表达,AKT / mTOR和Notch信号传导的调节作用。通过油红O染色分析了血清素在正常人肝细胞和肝癌细胞脂肪变性中的作用。通过qRT-PCR验证脂质/脂肪酸蛋白和5-羟色胺受体的mRNA表达水平。通过使用选择性抑制剂或拮抗剂,研究了自噬,Notch信号传导,5-羟色胺受体和5-羟色胺再摄取蛋白在5-羟色胺介导的细胞脂肪变性中的重要作用。还使用慢性EtOH喂养的小鼠模型研究了外周血清素,自噬和肝脂肪变性的相关性。肝癌细胞暴露于5-羟色胺诱导的Notch信号传导和自噬,独立于AKT / mTOR途径。而且,血清素增强了癌细胞的增殖/存活和耐药性。此外,血清素治疗可上调肝癌细胞中脂肪蛋白的表达并增加脂肪变性。自噬或Notch信号的抑制减少了5-羟色胺介导的细胞脂肪变性。用5-羟色胺受体拮抗剂5-HTr1B和5-HTr2B治疗可减少5-羟色胺介导的细胞脂肪变性。相反,使用选择性5-羟色胺再摄取抑制剂(SSRIs)进行治疗可增加脂肪变性。另外,用慢性EtOH喂养的小鼠导致血清5-羟色胺水平升高,这与诱导肝脂肪变性和自噬有关。 5-羟色胺调节肝癌细胞的脂肪变性,细胞存活,并可能通过激活Notch信号传导和自噬促进肝脏癌变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号